Focus Partners Wealth
RLAY icon

Focus Partners Wealth’s Relay Therapeutics RLAY Stock Holding History

Focus Partners Wealth’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,756
Closed -$107K – 2937
2026
Q1 		$107K Sell
10,756
-6,577
-38% -$58.8K ﹤0.01% 2504
2025
Q4 		$147K Buy
+17,333
New +$124K ﹤0.01% 2499
2025
Q3 		– Sell
-19,647
Closed -$68K – 2292
2025
Q2 		$68K Buy
+19,647
New +$58.4K ﹤0.01% 1964

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Focus Partners Wealth's RLAY Position: Q2 2026 in Review

Focus Partners Wealth sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 10,756 shares — an estimated $107K sold.

Focus Partners Wealth first reported a position in RLAY in Q2 2025 and held it in 3 quarters. The position peaked at $147K in Q4 2025. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Focus Partners Wealth reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Focus Partners Wealth sold 10,756 Relay Therapeutics shares in Q2 2026, an estimated $107K.
  • Focus Partners Wealth first reported a position in Relay Therapeutics in Q2 2025 and held it in 3 quarters.
  • Focus Partners Wealth's Relay Therapeutics position peaked at $147K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.